0001140361-21-016899.txt : 20210512 0001140361-21-016899.hdr.sgml : 20210512 20210511213023 ACCESSION NUMBER: 0001140361-21-016899 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210512 DATE AS OF CHANGE: 20210511 EFFECTIVENESS DATE: 20210512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aphria Inc. CENTRAL INDEX KEY: 0001733418 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-38708 FILM NUMBER: 21913206 BUSINESS ADDRESS: STREET 1: 245 TALBOT STREET W., SUITE 103 CITY: LEAMINGTON STATE: A6 ZIP: N8H 1N8 BUSINESS PHONE: (844) 427-4742 MAIL ADDRESS: STREET 1: 245 TALBOT STREET W., SUITE 103 CITY: LEAMINGTON STATE: A6 ZIP: N8H 1N8 15-12B 1 brhc10024464_1512b.htm 15-12B
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number:  001-38708

Aphria Inc.
(Exact name of registrant as specified in its charter)

98 Talbot Street West
Leamington, ON, Canada, N8H 1M8
(844) 427-4742
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Shares
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule 12g-4(a)(1)
☒
Rule 12g-4(a)(2)
☐
Rule 12h-3(b)(1)(i)
☒
Rule 12h-3(b)(1)(ii)
☐
Rule 15d-6
☐
Rule 15d-22(b)
☐

Approximate number of holders of record as of the certification or notice date: One

EXPLANATORY NOTE

On April 30, 2021, pursuant to an arrangement agreement, dated as of December 15, 2020, as amended on February 19, 2021, between Tilray, Inc. (“Tilray”) and Aphria Inc. (“Aphria”), Tilray and Aphria implemented an arrangement under the Business Corporations Act (Ontario) under which Tilray acquired all of the issued and outstanding common shares of Aphria.

Pursuant to the requirements of the Securities Exchange Act of 1934, Aphria Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 
APHRIA INC.
       
 
By:
/s/ Carl A. Merton
   
Name:
Carl A. Merton
   
Title:
Chief Financial Officer
       
DATE:  May 11, 2021